Your session is about to expire
← Back to Search
Chemotherapy
Angiomammography for Breast Cancer Response Prediction
N/A
Recruiting
Research Sponsored by CHU de Quebec-Universite Laval
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Neoadjuvant chemotherapy with or without concomitant targeted therapy
No evidence of distant metastasis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up cycle 2 (each cycle being 21 days), i.e., after the chemotherapy on day 1 of cycle 2 and before cycle 3.
Awards & highlights
Study Summary
This trial is looking at whether a less expensive and more readily available diagnostic modality, namely CESM, is as effective as MRI in predicting the response of a malignant breast tumor to neoadjuvant chemotherapy and the chances of achieving a pCR.
Who is the study for?
This trial is for women over 18 with breast cancer that hasn't spread far (no distant metastasis), measurable by examination. They must be undergoing neoadjuvant chemotherapy, possibly with additional targeted therapy. Exclusions include pregnancy, allergies to contrast dye, MRI contraindications, overt hyperthyroidism, and significant kidney failure.Check my eligibility
What is being tested?
The study compares two imaging techniques—CESM and MRI—to see which better predicts the absence of invasive cancer cells in the breast and lymph nodes after early rounds of chemotherapy. This could help switch treatments sooner for those not responding well.See study design
What are the potential side effects?
Potential side effects may relate to the use of contrast dyes during imaging tests such as allergic reactions or kidney issues. The MRI might not be suitable for people with certain implants or claustrophobia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have received chemotherapy before surgery, with or without targeted therapy.
Select...
My cancer has not spread to distant parts of my body.
Select...
My breast cancer was confirmed with a biopsy.
Select...
My breast tumor can be felt and measured by a doctor.
Select...
I am a woman aged 18 or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ cycle 2 (each cycle being 21 days), i.e., after the chemotherapy on day 1 of cycle 2 and before cycle 3.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~cycle 2 (each cycle being 21 days), i.e., after the chemotherapy on day 1 of cycle 2 and before cycle 3.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of patients with a pCR accoreding to angiomammography, based on a 50% reduction in lesion size at angiomammography
Trial Design
1Treatment groups
Experimental Treatment
Group I: Neoadjuvant chemotherapyExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
CHU de Quebec-Universite LavalLead Sponsor
167 Previous Clinical Trials
107,057 Total Patients Enrolled
4 Trials studying Breast Cancer
1,097 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have severe kidney problems.You have health conditions that make it unsafe for you to have an MRI scan.I have received chemotherapy before surgery, with or without targeted therapy.My cancer has not spread to distant parts of my body.You have a known reason that makes it unsafe for you to have contrast dye.My breast cancer was confirmed with a biopsy.My breast tumor can be felt and measured by a doctor.I have an overactive thyroid.I refuse to undergo a biopsy or surgery.You are allergic to contrast dye.I am a woman aged 18 or older.
Research Study Groups:
This trial has the following groups:- Group 1: Neoadjuvant chemotherapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining openings for participants in this trial?
"Affirmative. Clinicaltrials.gov maintains that this clinical trial, which was first posted on March 1st 2018, is currently recruiting patients from one location with a total of 100 participants needed."
Answered by AI
How many people are actively participating in this experiment?
"Affirmative, the available information from clinicaltrials.gov states that this experiment is actively recruiting volunteers. It was published on March 1st 2018 and updated June 10th 2022, seeking 100 individuals from one site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger